There are 2789 resources available
353P - Treatment outcome of temozolomide in elderly patients with glioblastoma: A systematic review
Presenter: Axel Sebastian
Session: ePoster Display
502P - Impact of different selection approaches for identifying Lynch syndrome-related colorectal cancer patients
Presenter: Daniele Fanale
Session: ePoster Display
503P - Mutational landscape in synchronous unresectable metastatic colorectal cancer (mCRC) according to upfront primary tumour resection (UPTR)
Presenter: Manuel Benavides
Session: ePoster Display
505TiP - REGINA: A phase II trial of neoadjuvant regorafenib (rego) in combination with nivolumab (nivo) and short-course radiotherapy (SCRT) in intermediate-risk, stage II-III rectal cancer (RC)
Presenter: Giacomo Bregni
Session: ePoster Display
509TiP - REPROGRAM-01, a phase II study of regorafenib in combination with a multimodal metronomic chemotherapy in patients with metastatic colorectal cancer
Presenter: Elodie Klajer
Session: ePoster Display
524P - A phase I, open-label, dose-escalation trial of BI 1701963 in patients (pts) with KRAS mutated solid tumours: A snapshot analysis
Presenter: Melissa Johnson
Session: ePoster Display
396P - Resectability, resections, systemic treatment and outcomes in elderly metastatic colorectal cancer (mCRC) patients (the RAXO study)
Presenter: Pia Osterlund
Session: ePoster Display
397P - R-IMMUNE interim analysis: A phase Ib/II study to evaluate safety and efficacy of atezolizumab combined with radio-chemotherapy in a preoperative setting for patients with localized rectal cancer
Presenter: Javier Carrasco
Session: ePoster Display
471P - Prognostic role of preoperative direct bilirubin-to-indirect bilirubin ratio and neutrophils-to-lymphocytes in resectable colorectal cancer
Presenter: Yifei Ma
Session: ePoster Display